SCHEMBL484790

SCHEMBL484790

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5ccc(F)cc5F)CC4)C3)cc21)c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 10/20 0.40
MAPK1 P28482 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
TAS1R2 Q8TE23 1/20 0.40
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP3A4 P08684 5/20 0.39
CYP1A2 P05177 2/20 0.39
HPGD P15428 2/20 0.39
DRD1 P21728 1/20 0.39
TSHR P16473 2/20 0.38
RECQL P46063 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 1/20 0.37
SPTLC2 O15270 1/20 0.37
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484943 0.96 CYP2D6 (0.45) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2
SCHEMBL484286 0.95 CYP2D6 (0.41) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2
SCHEMBL484741 0.94 CYP2D6 (0.42) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2
SCHEMBL2816489 0.91 CYP2D6 (0.37) CYP2D6MAPK1ALDH1A1CYP3A4CYP1A2
SCHEMBL484773 0.91 CYP2D6 (0.45) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2
SCHEMBL485310 0.90 CYP2D6 (0.46) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2
SCHEMBL484702 0.90 TAS1R3 (0.43) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2
SCHEMBL484520 0.90 CRHR1 (0.40) CYP2D6ALDH1A1CYP3A4CYP1A2TSHR
SCHEMBL484446 0.89 TAS1R3 (0.43) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2
SCHEMBL484382 0.89 ALDH1A1 (0.42) CYP2D6MAPK1TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885MAPK1 1001/4885TAS1R3 339/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885MAPK1 1001/4885TAS1R3 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.